MARATTO

article · PubMed

Evolutionary Dynamics of Bluetongue virus serotypes 3, 4, and 8 circulating in Italy, 2024-2025.

Abstract

Bluetongue virus (BTV) continues to pose a major threat to ruminant health in Europe, where repeated introductions, the co-circulation of multiple serotypes and frequent reassortment shape its genomic diversity. During 2024-2025, Italy experienced a marked resurgence of bluetongue, driven mainly by BTV-3 and BTV-8. In this study, we performed whole-genome sequencing of BTV-3, BTV-4 and BTV-8 strains collected in Italy during 2024-2025 and integrated these data with representative genomes from Italy and Tunisia generated over the previous decade. A total of 47 BTV whole-genome sequences were analysed. Multiple reassortant genomic constellations were identified among BTV-3 and BTV-4 strains, reflecting extensive segment exchange between North African and European lineages. In contrast, all Italian BTV-8 genomes showed near-complete nucleotide identity with the contemporary BTV-8 FRA 2023 lineage, indicating nationwide circulation of a single strain. Despite its widespread diffusion, BTV-8 did not acquire heterologous genome segments, whereas its internal genes were frequently incorporated into BTV-3 and BTV-4 genomic backgrounds. These findings highlight Italy as a key convergence point for BTV lineages in the Mediterranean basin and underscore the value of whole-genome surveillance for tracking viral introductions and reassortment dynamics.

Research topics

  • Vector-Borne Animal Diseases
  • Virology and Viral Diseases
  • Animal Disease Management and Epidemiology

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.12834/vetit.3915.38031.1

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.